Cargando…
Mesenteric fat as a source of C reactive protein and as a target for bacterial translocation in Crohn's disease
OBJECTIVE: Mesenteric fat hyperplasia is a hallmark of Crohn's disease (CD), and C reactive protein (CRP) is correlated with disease activity. The authors investigated whether mesenteric adipocytes may be a source of CRP in CD and whether inflammatory and bacterial triggers may stimulate its pr...
Autores principales: | Peyrin-Biroulet, Laurent, Gonzalez, Florent, Dubuquoy, Laurent, Rousseaux, Christel, Dubuquoy, Caroline, Decourcelle, Cécilia, Saudemont, Alain, Tachon, Mickael, Béclin, Elodie, Odou, Marie-Françoise, Neut, Christel, Colombel, Jean-Frédéric, Desreumaux, Pierre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Group
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3230831/ https://www.ncbi.nlm.nih.gov/pubmed/21940721 http://dx.doi.org/10.1136/gutjnl-2011-300370 |
Ejemplares similares
-
Disease clearance in ulcerative colitis: Is the ultimate therapeutic target?
por: D’Amico, Ferdinando, et al.
Publicado: (2023) -
Development of the first disability index for inflammatory bowel disease based on the international classification of functioning, disability and health
por: Peyrin-Biroulet, Laurent, et al.
Publicado: (2011) -
Ustekinumab is more effective than azathioprine to prevent endoscopic postoperative recurrence in Crohn's disease
por: Buisson, Anthony, et al.
Publicado: (2021) -
Has the therapeutical ceiling been reached in Crohn's disease randomized controlled trials? A systematic review and meta‐analysis
por: Magro, Fernando, et al.
Publicado: (2023) -
Landscape of new drugs and targets in inflammatory bowel disease
por: Vieujean, Sophie, et al.
Publicado: (2022)